Hunan Province Tumor Hospital
Clinical trials sponsored by Hunan Province Tumor Hospital, explained in plain language.
-
Morning vs. afternoon: timing may boost lung cancer therapy
Knowledge-focused Recruiting nowThis study looks at whether giving immunotherapy in the morning or afternoon changes how well it works for people with stage II-III lung cancer that can be removed by surgery. About 156 participants will get standard treatment plus either a morning or afternoon infusion. The goal…
Phase: PHASE3 • Sponsor: Hunan Province Tumor Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 09:58 UTC
-
Scientists probe genetic secrets of lung cancer relapse after promising drug
Knowledge-focused Recruiting nowThis study looks at 60 adults with early-stage (IB-IIIA) non-small cell lung cancer whose cancer came back after surgery and treatment with the drug osimertinib. Researchers will analyze tumor or blood samples to find genetic changes linked to the recurrence. The goal is to bette…
Sponsor: Hunan Province Tumor Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 09:52 UTC